company background image
MED logo

Medifast NYSE:MED Voorraadrapport

Laatste prijs

US$18.81

Marktkapitalisatie

US$197.9m

7D

5.4%

1Y

-73.4%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

MED Overzicht aandelen

Medifast, Inc. houdt zich via haar dochterondernemingen bezig met de productie en verkoop van producten voor gewichtsverlies, gewichtsbeheersing en gezond leven in de Verenigde Staten en Azië-Pacific.

Medifast, Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Medifast
Historische aandelenkoersen
Huidige aandelenkoersUS$18.81
52 Week HoogtepuntUS$76.42
52 Week LaagUS$17.07
Bèta1.16
11 maand verandering2.01%
3 maanden verandering-7.20%
1 Jaar Verandering-73.38%
33 jaar verandering-91.44%
5 jaar verandering-76.65%
Verandering sinds IPO242.00%

Recent nieuws en updates

Medifast: Reorganization, GLP-1 Medication, And FCF Imply Undervaluation

Sep 03

Medifast Business Continues To Shrink, Stock Still Risky

Aug 27

Recent updates

Medifast: Reorganization, GLP-1 Medication, And FCF Imply Undervaluation

Sep 03

Medifast Business Continues To Shrink, Stock Still Risky

Aug 27

Medifast: GLP-1 Fears Are Overblown, But Proof Points For Turnaround Are Still Missing

Jun 26

Medifast: Significant Undervaluation Even As Struggles Persist

May 24

At US$22.76, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?

May 24
At US$22.76, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?

Lacklustre Performance Is Driving Medifast, Inc.'s (NYSE:MED) 32% Price Drop

May 24
Lacklustre Performance Is Driving Medifast, Inc.'s (NYSE:MED) 32% Price Drop

Medifast's (NYSE:MED) Conservative Accounting Might Explain Soft Earnings

May 06
Medifast's (NYSE:MED) Conservative Accounting Might Explain Soft Earnings

The Returns On Capital At Medifast (NYSE:MED) Don't Inspire Confidence

May 01
The Returns On Capital At Medifast (NYSE:MED) Don't Inspire Confidence

Medifast: Cheap Valuation, Uncertain Future

Mar 20

Medifast Is Getting Attractive

Mar 07

Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings

Feb 22
Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings

Medifast Share Price Loses Weight, But Is There Still Value To Be Had?

Jan 20

Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?

Dec 09
Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?

Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome

Nov 24

Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?

Nov 21
Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?

Medifast: Unveiling A Challenge Beyond Weight Loss Drugs

Nov 09

Medifast: The Race To Weight-Loss Drugs Not Lost Yet

Oct 09

Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs

Aug 04

Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?

Jul 26
Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?

In The Murky MLM Space, Medifast Might Actually Hold Some Promise

Jul 21

Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Jul 05
Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Medifast: In Survival Mode Against Diet Pills And The Recession

Jun 14

Medifast Holds Value During Headwinds

May 28

Medifast Non-GAAP EPS of $3.70 beats by $1.48, revenue of $337.2M beats by $7.1M

Feb 21

Medifast: A Low Earnings Multiple Despite Strong Financial Performance

Feb 07

At US$117, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?

Jan 19
At US$117, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?

Medifast declares $1.64 dividend

Dec 08

A Look At The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Dec 01
A Look At The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Medifast's (NYSE:MED) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Nov 10
Medifast's (NYSE:MED) Sluggish Earnings Might Be Just The Beginning Of Its Problems

One Medifast, Inc. (NYSE:MED) Analyst Just Made A Major Cut To Next Year's Estimates

Nov 08
One Medifast, Inc. (NYSE:MED) Analyst Just Made A Major Cut To Next Year's Estimates

Medifast: This High-Yield Blue Chip Dividend Stock Is A Strong Buy

Nov 06

What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?

Oct 20
What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?

We Think Medifast (NYSE:MED) Can Stay On Top Of Its Debt

Sep 18
We Think Medifast (NYSE:MED) Can Stay On Top Of Its Debt

Medifast declares $1.64 dividend

Sep 08

Do Medifast's (NYSE:MED) Earnings Warrant Your Attention?

Sep 02
Do Medifast's (NYSE:MED) Earnings Warrant Your Attention?

Medifast: Let's Dive Into Its Q2 Earnings And Assess The Bad And The Good

Aug 21

Medifast, Inc. (NYSE:MED) Analysts Are Reducing Their Forecasts For This Year

Aug 09
Medifast, Inc. (NYSE:MED) Analysts Are Reducing Their Forecasts For This Year

Rendement voor aandeelhouders

MEDUS Personal ProductsUS Markt
7D5.4%-8.5%-1.9%
1Y-73.4%-10.0%30.4%

Rendement versus industrie: MED presteerde slechter dan de US Personal Products -sector, die het afgelopen jaar een rendement van -10 % opleverde.

Rendement versus markt: MED presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.4 % opleverde.

Prijsvolatiliteit

Is MED's price volatile compared to industry and market?
MED volatility
MED Average Weekly Movement5.3%
Personal Products Industry Average Movement7.8%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: MED heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van MED is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1980634Dan Chardmedifastinc.com

Medifast, Inc. houdt zich via haar dochterondernemingen bezig met de productie en verkoop van producten voor gewichtsverlies, gewichtsbeheersing en gezond leven in de Verenigde Staten en Azië-Pacific. Het biedt repen, soesjes, ontbijtgranen, crunchers, drankjes, hartige keuzes, havermout, pannenkoeken, pudding, soft serve, shakes, smoothies, soft bakes en soepen onder de merknamen OPTAVIA, OPTAVIA ACTIVE en Optimal Health. Het bedrijf brengt zijn producten op de markt via verkooppunttransacties en via het e-commerce platform.

Medifast, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Medifast zich tot de beurswaarde?
MED fundamentele statistieken
MarktkapitalisatieUS$197.90m
Inkomsten(TTM)US$29.33m
Inkomsten(TTM)US$770.18m

6.8x

Koers/Winstverhouding

0.3x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
MED resultatenrekening (TTM)
InkomstenUS$770.18m
Kosten van inkomstenUS$200.71m
BrutowinstUS$569.48m
Overige uitgavenUS$540.15m
InkomstenUS$29.33m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)2.75
Brutomarge73.94%
Nettowinstmarge3.81%
Schuld/Eigen Vermogen Verhouding0%

Hoe presteerde MED op de lange termijn?

Bekijk historische prestaties en vergelijking